Brand and Other Names:Axona, caprylic triglyceride
- Classes: Nutritionals, Other
Dosing & Uses
Dosage Forms & Strengths
- 40g/packet (each 40g packet contains 20g of medium chain triglycerides [MCTs])
Indicated for clinical dietary management of metabolic processes associated with mild-to-moderate Alzheimer disease
40 g (1 packet of powder, containing 20 g MCTs) PO qDay
Mix contents of each 40 g packet with 4-8 oz of water; shake until fully blended and drink immediately
Reconstituted product may be refrigerated for up to 24 hr, then reblended and thoroughly mixed before consumption
If GI adverse effects occur, may temporarily give simethicone, antacids, or antidiarrheal agents
For persistent GI symptoms, decrease dose to one-half packet qDay until adverse effects resolve, then resume taking full packet
Additional Supplement Ingredients
Also contains potassium caseinate (milk-derived protein), maltodextrin, whey protein (milk-derived), sugar, sunflower oil, dimagnesium phosphate, tricalcium phosphate, dipotassium phosphate, soy lecithin, distilled monoglyceride, sodium ascorbate (vitamin C), silicon dioxide, natural vanilla bean extract, vitamin E acetate, vitamin A palmitate, zinc sulfate, pyridoxine HCl (vitamin B6), folic acid, and chromium chloride
Allergy to milk or soy (contains caseinate, whey, and lecithin)
Hypersensitivity to palm or coconut oil
Patients at risk for ketoacidosis (eg, alcoholics, poorly controlled diabetics)
History of GI inflammatory conditions (eg, IBS, diverticulitis, chronic gastritis, GERD)
May increase triglycerides (periodically monitor serum triglyceride level)
Renal effects: may increase BUN, uric acid, or serum creatinine
Pregnancy & Lactation
Pregnancy Category: C; not studied in women <50 years old
Lactation: Unknown whether distributed in breast milk, caution advised
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.
Mechanism of Action
Prescription medical food metabolized into ketone bodies to product hyperketonemia, thus provides an alternate glucose substrate to brain
The brain can use these ketone bodies for energy when its ability to process glucose is impaired
Brain-imaging scans of older adults and those with Alzheimer disease reveal a dramatically decreased uptake of glucose
To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.
Adding plans allows you to:
- View the formulary and any restrictions for each plan.
- Manage and view all your plans together – even plans in different states.
- Compare formulary status to other drugs in the same class.
- Access your plan list on any device – mobile or desktop.
The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.
|1||This drug is available at the lowest co-pay. Most commonly, these are generic drugs.|
|2||This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.|
|3||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.|
|4||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|5||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|6||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|NC||NOT COVERED – Drugs that are not covered by the plan.|
Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
Select a box to add or remove a plan.
Select a class to view formulary status for similar drugs